Skip to main content

Advertisement

Log in

Systemic inflammation and delirium during critical illness

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to determine associations between markers of inflammation and endogenous anticoagulant activity with delirium and coma during critical illness.

Methods

In this prospective cohort study, we enrolled adults with respiratory failure and/or shock treated in medical or surgical intensive care units (ICUs) at 5 centers. Twice per day in the ICU, and daily thereafter, we assessed mental status using the Richmond Agitation Sedation Scale (RASS) and the Confusion Assessment Method-Intensive Care Unit (CAM-ICU). We collected blood samples on study days 1, 3, and 5, measuring levels of C-reactive protein (CRP), interferon gamma (IFN-γ), interleukin (IL)-1 beta (IL-1β), IL-6, IL-8, IL-10, IL-12, matrix metalloproteinase-9 (MMP-9), tumor necrosis factor-alpha (TNF-α), tumor necrosis factor receptor 1 (TNFR1), and protein C using validated protocols. We used multinomial logistic regression to analyze associations between biomarkers and the odds of delirium or coma versus normal mental status the following day, adjusting for age, sepsis, Sequential Organ Failure Assessment (SOFA), study day, corticosteroids, and sedatives.

Results

Among 991 participants with a median age (interquartile range, IQR) of 62 [53–72] years and enrollment SOFA of 9 [7–11], higher concentrations of IL-6 (odds ratio [OR] [95% CI]: 1.8 [1.4–2.3]), IL-8 (1.3 [1.1–1.5]), IL-10 (1.5 [1.2–1.8]), TNF-α (1.2 [1.0–1.4]), and TNFR1 (1.3 [1.1–1.6]) and lower concentrations of protein C (0.7 [0.6–0.8])) were associated with delirium the following day. Higher concentrations of CRP (1.4 [1.1–1.7]), IFN-γ (1.3 [1.1–1.5]), IL-6 (2.3 [1.8–3.0]), IL-8 (1.8 [1.4–2.3]), and IL-10 (1.5 [1.2–2.0]) and lower concentrations of protein C (0.6 [0.5–0.8]) were associated with coma the following day. IL-1β, IL-12, and MMP-9 were not associated with mental status.

Conclusion

Markers of inflammation and possibly endogenous anticoagulant activity are associated with delirium and coma during critical illness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Data and supporting documents from this study are available for academic research purposes upon request from the Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN, USA (www.icudelirium.org).

References

  1. American Psychiatric Association, American Psychiatric Association, DSM-5 Task Force (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, Washington, D.C.

  2. Brummel NE, Girard TD (2019) Delirium in the critically ill patient. Handb Clin Neurol 167:357–375

    Article  PubMed  Google Scholar 

  3. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH (2009) Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 180:1092–1097

    Article  PubMed  PubMed Central  Google Scholar 

  4. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW (2010) Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 38:1513–1520

    Article  PubMed  PubMed Central  Google Scholar 

  5. Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW, Investigators B-IS (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369:1306–1316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Brummel NE, Jackson JC, Pandharipande PP, Thompson JL, Shintani AK, Dittus RS, Gill TM, Bernard GR, Ely EW, Girard TD (2014) Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit Care Med 42:369–377

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB (2010) The neuroinflammatory hypothesis of delirium. Acta Neuropathol 119:737–754

    Article  PubMed  Google Scholar 

  8. Cunningham C (2011) Systemic inflammation and delirium: important co-factors in the progression of dementia. Biochem Soc Trans 39:945–953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C (2008) Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 65:229–238

    Article  PubMed  PubMed Central  Google Scholar 

  10. van den Boogaard M, Kox M, Quinn KL, van Achterberg T, van der Hoeven JG, Schoonhoven L, Pickkers P (2011) Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care 15:R297

    Article  PubMed  PubMed Central  Google Scholar 

  11. McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely EW, Pandharipande PP (2011) Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 15:R78

    Article  PubMed  PubMed Central  Google Scholar 

  12. Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, Jackson JC, Dittus RS, Ely EW (2012) Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med 38:1965–1973

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Skrobik Y, Leger C, Cossette M, Michaud V, Turgeon J (2013) Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 41:999–1008

    Article  CAS  PubMed  Google Scholar 

  14. Ritter C, Tomasi CD, Dal-Pizzol F, Pinto BB, Dyson A, de Miranda AS, Comim CM, Soares M, Teixeira AL, Quevedo J, Singer M (2014) Inflammation biomarkers and delirium in critically ill patients. Crit Care 18:R106

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zhang Z, Pan L, Deng H, Ni H, Xu X (2014) Prediction of delirium in critically ill patients with elevated C-reactive protein. J Crit Care 29:88–92

    Article  CAS  PubMed  Google Scholar 

  16. Khan BA, Perkins AJ, Prasad NK, Shekhar A, Campbell NL, Gao S, Wang S, Khan SH, Marcantonio ER, Twigg HL 3rd, Boustani MA (2020) Biomarkers of delirium duration and delirium severity in the ICU. Crit Care Med 48:353–361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hughes CG, Patel MB, Jackson JC, Girard TD, Geevarghese SK, Norman BC, Thompson JL, Chandrasekhar R, Brummel NE, May AK, Elstad MR, Wasserstein ML, Goodman RB, Moons KG, Dittus RS, Ely EW, Pandharipande PP, Mind-Icu B-ICUi (2017) Surgery and anesthesia exposure is not a risk factor for cognitive impairment after major noncardiac surgery and critical illness. Ann Surg 265:1126–1133

    Article  PubMed  Google Scholar 

  18. Bastarache JA, Koyama T, Wickersham NE, Ware LB (2014) Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples. J Immunol Methods 408:13–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR (2003) Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 289:2983–2991

    Article  PubMed  Google Scholar 

  20. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286:2703–2710

    Article  CAS  PubMed  Google Scholar 

  21. van Gool WA, van de Beek D, Eikelenboom P (2010) Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 375:773–775

    Article  PubMed  Google Scholar 

  22. Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition: the case for a head to toe inflammatory paradigm. JAGS 50:2041–2056

    Article  Google Scholar 

  23. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, Deacon RM, Rawlins JN, Perry VH (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65:304–312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Murray C, Sanderson DJ, Barkus C, Deacon RM, Rawlins JN, Bannerman DM, Cunningham C (2012) Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol Aging 33:603–616

  25. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452

    Article  CAS  PubMed  Google Scholar 

  26. Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H (2005) Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 19:453–460

    Article  CAS  PubMed  Google Scholar 

  27. Plaschke K, Fichtenkamm P, Schramm C, Hauth S, Martin E, Verch M, Karck M, Kopitz J (2010) Early postoperative delirium after open-heart cardiac surgery is associated with decreased bispectral EEG and increased cortisol and interleukin-6. Intensive Care Med 36:2081–2089

    Article  CAS  PubMed  Google Scholar 

  28. van Munster BC, Korevaar JC, Zwinderman AH, Levi M, Wiersinga WJ, De Rooij SE (2008) Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 56:1704–1709

    Article  PubMed  Google Scholar 

  29. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC, Gen IMSI (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167:1655–1663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Christiaans SC, Wagener BM, Esmon CT, Pittet JF (2013) Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol 305:L455-466

    Article  CAS  PubMed  Google Scholar 

  31. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL, Administration of Drotrecogin Alfa in Early Stage Severe Sepsis Study G (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332–1341

    Article  CAS  PubMed  Google Scholar 

  32. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis Study Group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  CAS  PubMed  Google Scholar 

  33. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064

    Article  CAS  PubMed  Google Scholar 

  34. Petraglia AL, Marky AH, Walker C, Thiyagarajan M, Zlokovic BV (2010) Activated protein C is neuroprotective and mediates new blood vessel formation and neurogenesis after controlled cortical impact. Neurosurgery 66:165–171

    Article  PubMed  Google Scholar 

  35. Brummel NE, Hughes CG, Thompson JL, Jackson JC, Pandharipande P, McNeil JB, Raman R, Orun OM, Ware LB, Bernard GR, Ely EW, Girard TD (2021) Inflammation and coagulation during critical illness and long-term cognitive impairment and disability. Am J Respir Crit Care Med 203:699–706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Arbabi M, Ziaei E, Amini B, Ghadimi H, Rashidi F, Shohanizad N, Moradi S, Beikmarzehei A, Hasanzadeh A, Parsaei A (2022) Delirium risk factors in hospitalized patient: a comprehensive evaluation of underlying diseases and medications in different wards of a large Urban Hospital Center in Iran. BMC Anesthesiol 22:147

    Article  PubMed  PubMed Central  Google Scholar 

  37. D’Ardes D, Carrarini C, Russo M, Dono F, Speranza R, Digiovanni A, Martinotti G, Di Iorio A, Onofrj M, Cipollone F, Bonanni L (2021) Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization. Neurol Sci 42:1527–1530

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the National Institutes of Health K76AG054864, K23AG034257, R01AG027472, R01AG035117) and VA MERIT. In addition, WE received support from the Veterans Affairs Tennessee Valley GRECC.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to study conception and design as well as acquisition, analysis, or interpretation of data. JLT, OMO, and RC conducted statistical analyses. All authors interpreted the results. NEB and TDG drafted the manuscript, and all authors critically revised the manuscript and approved the final version.

Corresponding author

Correspondence to Timothy D. Girard.

Ethics declarations

Conflicts of interest

CGH is a consultant for Sedana Medical and has received research grant from Kohler Chemie GMBH. PP has received a research grant from Hospira. WE has received research grants and/or honoraria from Hospira, Orion, Pfizer, Abbott, and Kohler Chemie GMBH. The remaining authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 275 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brummel, N.E., Hughes, C.G., McNeil, J.B. et al. Systemic inflammation and delirium during critical illness. Intensive Care Med 50, 687–696 (2024). https://doi.org/10.1007/s00134-024-07388-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-024-07388-6

Keywords

Navigation